Who’s really in charge at Anthropic after the IPO?

Anthropic’s proposed IPO-era governance structure would give its Long Term Benefit Trust the power to elect and remove a majority of the board, while the seven founders jointly hold 50.1% of shareholder voting power and can elect three directors. Common shareholders would have limited control initially, although employee votes can affect certain LTBT board decisions, and founder control can end 10 years after the IPO or when fewer than three founders remain. The long-term dynamics are uncertain; the article compares the employee influence built into Anthropic’s structure with OpenAI’s 2023 board crisis.

Analysis

The investable issue is not governance complexity by itself, but whether IPO pricing compensates buyers for limited control. A control discount is plausible: ordinary shareholders may have little leverage over board composition or strategy, weakening activist, proxy, and change-of-control optionality. That can narrow the natural buyer base and matter most if the offering is priced against public software peers with conventional shareholder rights. Conversely, mission protection may reduce pressure to monetize safety-sensitive capabilities prematurely and could support employee and customer trust—an economic asset if safety becomes a procurement or regulatory differentiator.

The less obvious risk is a multi-principal problem: founders, the trust, the board, and employees may each have effective veto points. In a strategic dispute, employee influence could constrain commercial pivots even where management and investors favor them; a founder split could also make control less predictable than the formal structure suggests. Over 1–3 months, the prospectus, voting terms, and IPO valuation should drive any repricing. Over 6–18 months, watch for evidence that governance slows product deployment, partnerships, or capital allocation—or instead helps retain talent and win trust-sensitive business. The article provides no basis for attributing operating or financial effects to MSFT, NFLX, GM, or NVS; their named individuals’ affiliations are not company-level catalysts.

Key Decisions for Investors

• Do not trade MSFT, NFLX, GM, or NVS on this governance story; the article establishes no change to their fundamentals.
• For a prospective Anthropic IPO, require the final prospectus and share-class terms before underwriting governance risk: verify the exact common-share voting rights, board-selection mechanics, trust succession, and any sunset provisions. Treat unclear or weaker-than-expected protections as a reason to demand a valuation discount, not as a quantified target.
• In the first 1–3 months after pricing, monitor book quality, aftermarket performance, and any disclosed investor-rights limitations. If valuation implies ordinary public-company governance despite structurally constrained shareholder influence, consider an underweight versus a diversified AI exposure; avoid a short until borrow, valuation, and comparable exposure are observable.
• Over 6–18 months, track product-release cadence, major commercial partnerships, employee retention, and management guidance for signs that mission safeguards are either a trust advantage or an execution constraint. The thesis weakens if the company demonstrates competitive deployment and durable demand without material governance friction.